| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC | Interim CFO | Common Stock | 52,656 | $639,243 | $12.14 | 20 Jan 2026 | Direct |
| OCULAR THERAPEUTIX, INC | Interim CFO | Stock Option (Right to Buy) | 33,000 | 20 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | 20 Jan 2026 | 1 | $0 | 4 | Interim CFO | 22 Jan 2026, 18:41 |
| OCUL | OCULAR THERAPEUTIX, INC | 20 Jan 2026 | 0 | $0 | 3 | Interim CFO | 22 Jan 2026, 18:39 |